At ACMG, GUARDIAN Newborn Sequencing Study Reports High Uptake Rate
The researchers have already identified babies with G6PD deficiency who would have been missed by standard newborn screening.
GeneDx Q4 Revenues Grow 6 Percent but Miss Consensus Estimate
The firm reiterated an earlier forecast of $205 million to $220 million in revenues for 2023, representing a slight decline over 2022.
People in the News at Wellcome Sanger Institute, Boston Children's Hospital, Arima Genomics, More
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of Feb. 13, 2023.
In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More
News items for the week of Jan. 30, 2023.
GeneDx to Raise $150M in Public and Direct Stock Offerings
Expected to close Jan. 31, the stock sales are intended to help the firm build up working capital, repay debts, and make strategic investments.
May 13, 2022
May 12, 2022
Sema4 Q1 Revenues Decline 16 Percent
Apr 21, 2022
Jan 20, 2022
Jan 18, 2022